AN ACT REQUIRING THE PROVISION OF WRITTEN INFORMATION BY PHARMACISTS CONCERNING THE EFFECTS OF MIFEPRISTONE WHEN DISPENSING TO A PATIENT.

HB 5714 requires pharmacists to provide written information to patients receiving mifepristone (a medication used to terminate pregnancy) about the possibility that pregnancy effects may be reversed if the patient later decides to continue the pregnancy and seeks timely reversal treatment. This applies directly to pharmacists dispensing mifepristone and the patients who receive it. The bill mandates that this written notice be provided at the time of dispensing, as stated in the bill's purpose to "protect reproductive rights" in cases where a patient changes their mind. The key provision is the requirement for pharmacists to deliver this specific written notice, without altering the standard dispensing process.